Stability of amorphous indomethacin compounded with silica.
暂无分享,去创建一个
M Ikeda | M. Senna | T. Isobe | M. Ikeda | Tomoyuki Watanabe | T. Watanabe | N. Wakiyama | T Watanabe | N Wakiyama | F Usui | T Isobe | M Senna | F. Usui | Ikeda Masaru
[1] Bruno C. Hancock,et al. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. , 1995, Journal of pharmaceutical sciences.
[2] D. Grant,et al. Solid‐state 13C NMR study of drugs: Aspirin , 1986 .
[3] G. Zografi,et al. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. , 1997, Journal of pharmaceutical sciences.
[4] Keiji. Yamamoto,et al. Dissolution improvement of RS-8359 by the solid dispersion prepared by the solvent method , 1998 .
[5] S. Georgieva,et al. Aspects of the interactions between indomethacin and nicotinamide in solid dispersions , 1998 .
[6] C. Nyström,et al. Comparison of solid-state NMR and isothermal microcalorimetry in the assessment of the amorphous component of lactose , 1998 .
[7] S. Lin. Isolation and solid-state characteristics of a new crystal form of indomethacin. , 1992, Journal of pharmaceutical sciences.
[8] T. Fukuchi. Vacancy-associated type ESR centers observed in natural silica and their application to geology , 1993 .
[9] N Kaneniwa,et al. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. , 1986, Chemical & pharmaceutical bulletin.
[10] Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation. , 1997, Journal of pharmaceutical and biomedical analysis.
[11] D. Middleton,et al. A cross-polarization magic-angle spinning 13C NMR characterization of the stable solid-state forms of cimetidine. , 1997, Journal of pharmaceutical sciences.
[12] F. Hirayama,et al. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior. , 1999, Journal of pharmaceutical sciences.
[13] Bruno C. Hancock,et al. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. , 1994, Journal of pharmaceutical sciences.
[14] S. Hirota,et al. Mechano-chemical formation of indomethacin β cyclodextrin inclusion compounds in powder phase roll mixtures , 1997 .
[15] C. Cimpoiu,et al. The control over the new obtaining procedeum of indomethacin. , 1998, Journal of pharmaceutical and biomedical analysis.
[16] R. Brückner,et al. Properties and structure of vitreous silica. I , 1970 .
[17] T. Eguchi,et al. Solid-State Characterization of Candesartan Cilexetil (TCV-116): Crystal Structure and Molecular Mobility , 1999 .
[18] C. W. Price. Use of Kolmogorov-Johnson-Mehl-Avrami kinetics in recrystallization of metals and crystallization of metallic glasses , 1990 .
[19] L. Facchini,et al. Silicon-29 NMR study of silica , 1992 .
[20] D. A. Williams,et al. Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. I. Formation studies , 1998 .
[21] M. Vachon,et al. The use of 13C solid state NMR to elucidate physico-chemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acid. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] D. Law,et al. Nucleation and crystallization kinetics of hydrated amorphous lactose above the glass transition temperature. , 1999, Journal of pharmaceutical sciences.